Bulletin
Investor Alert

New York Markets Close in:

Esperion Therapeutics Inc.

NAS: ESPR

GO
/marketstate/country/us

Market open

/zigman2/quotes/207049816/composite

$

37.06

Change

+1.01 +2.80%

Volume

Volume 132,097

Sep 25, 2020, 1:21 p.m.

Real time quotes

/zigman2/quotes/207049816/composite

Previous close

$ 36.05

$ 37.06

Change

+1.01 +2.80%

Day low

Day high

$35.60

$37.13

Open
Open: 35.60

52 week low

52 week high

$24.82

$76.98

Open

Market cap

$1.00B

Average volume

638,539

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-3.30

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/espr

MarketWatch News on ESPR

  1. Esperion Therapeutics stock price target raised to $47 from $38 at J.P. Morgan

    8:17 a.m. March 13, 2019

    - Tomi Kilgore

  2. Esperion Therapeutics upgraded to neutral from underweight at J.P. Morgan

    8:15 a.m. March 13, 2019

    - Tomi Kilgore

  3. Esperion Therapeutics initiated at sell buy Goldman Sachs

    9:25 a.m. Dec. 13, 2018

    - Emily Bary

  4. Esperion Therapeutics price target lifted to $104 from $89 at Stifel

    9:32 a.m. Dec. 10, 2018

    - Tonya Garcia

  5. Esperion shares resume trading after halt up 1.9%

    7:32 a.m. Aug. 27, 2018

    - Ciara Linnane

  6. Esperion Therapeutics announces positive results in late-stage trial of ASCVD treatment

    7:03 a.m. Aug. 27, 2018

    - Ciara Linnane

  7. Esperion Therapeutics stock halted for news pending

    6:58 a.m. Aug. 27, 2018

    - Ciara Linnane

  8. Esperion’s Top Holder Buys $5.2 Million More in Stock

    11:26 a.m. May 23, 2018

    - Barrons Blogs

  9. Esperion shares halted on late-stage trial results

    8:39 a.m. May 23, 2018

    - Emma Court

  10. Esperion shares halted on late-stage trial results

    8:25 a.m. May 23, 2018

    - Emma Court

  11. Esperion Therapeutics stock price target cut to $75 from $90 at UBS

    1:28 p.m. May 16, 2018

    - Tomi Kilgore

  12. Charting the Market

    8:00 p.m. May 4, 2018

    - Barron's Online

  13. Esperion Therapeutics downgraded to underweight from neutral at J.P. Morgan

    7:42 a.m. May 3, 2018

    - Tomi Kilgore

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/espr

Other News on ESPR

  1. Esperion Therapeutics (ESPR) Beats Q2 Earnings Estimates

    5:15 p.m. Aug. 10, 2020

    - Zacks.com

  2. Esperion Therapeutics Q2 2020 Earnings Preview

    5:35 p.m. Aug. 9, 2020

    - Seeking Alpha

  3. Top Stocks To Buy On A Sell-Off

    11:29 a.m. July 13, 2020

    - Seeking Alpha

  4. Esperion Therapeutics: An Easy Double, Maybe A Lot More

    1:43 a.m. June 26, 2020

    - Seeking Alpha

  5. The Play On Esperion Therapeutics

    12:08 p.m. June 19, 2020

    - Seeking Alpha

  6. Esperion Therapeutics' Festive Q1 2020 Earnings Call

    6:28 a.m. May 13, 2020

    - Seeking Alpha

  7. Drugmakers Overhaul the Sales Pitch Amid Coronavirus Lockdowns

    7:20 p.m. May 11, 2020

    - The Wall Street Journal Interactive Edition

  8. Needham sees 258% upside in this pharma after Q1 sales taste

    7:46 p.m. May 7, 2020

    - Seeking Alpha

  9. Loading more headlines...
/news/pressrelease/company/us/espr

Press Releases on ESPR

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.